TIPICO X: report of the 10th interactive infectious disease workshop on infectious diseases and vaccines

Publication date

2021-03-04

Authors

Rivero-Calle, Irene
Gómez-Rial, Jose
Bont, Louis JISNI 0000000394182070
Gessner, Bradford D
Kohn, Melvin
Dagan, Ron
Payne, Daniel C
Bruni, Laia
Pollard, Andrew J
García-Sastre, Adolfo

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

Abstract

TIPICO is an expert meeting and workshop that aims to provide the most recent evidence in the field of infectious diseases and vaccination. The 10th Interactive Infectious Disease TIPICO workshop took place in Santiago de Compostela, Spain, on November 21-22, 2019. Cutting-edge advances in vaccination against respiratory syncytial virus, Streptococcus pneumoniae, rotavirus, human papillomavirus, Neisseria meningitidis, influenza virus, and Salmonella Typhi were discussed. Furthermore, heterologous vaccine effects were updated, including the use of Bacillus Calmette-Guérin (BCG) vaccine as potential treatment for type 1 diabetes. Finally, the workshop also included presentations and discussion on emergent virus and zoonoses, vaccine resilience, building and sustaining confidence in vaccination, approaches to vaccine decision-making, pros and cons of compulsory vaccination, the latest advances in decoding infectious diseases by RNA gene signatures, and the application of big data approaches.

Keywords

Infectious disease, RNA gene signatures, big data, emergent virus, off-target effects, transcriptomics, vaccine hesitancy, vaccine resilience, vaccine-preventable diseases, zoonoses, Immunology and Allergy, Pharmacology, Immunology, Journal Article

Citation

Rivero-Calle, I, Gómez-Rial, J, Bont, L, Gessner, B D, Kohn, M, Dagan, R, Payne, D C, Bruni, L, Pollard, A J, García-Sastre, A, Faustman, D L, Osterhaus, A, Butler, R, Giménez Sánchez, F, Álvarez, F, Kaforou, M, Bello, X & Martinón-Torres, F 2021, 'TIPICO X : report of the 10th interactive infectious disease workshop on infectious diseases and vaccines', Human vaccines & immunotherapeutics, vol. 17, no. 3, pp. 759-772. https://doi.org/10.1080/21645515.2020.1788301